Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 5,045 | 4,454 | 7,418 | 6,780 | 8,034 |
| Cost of Goods | 2,963 | 2,174 | 6,101 | 8,708 | 5,199 |
| Gross Profit | 2,082 | 2,280 | 1,317 | -1,928 | 2,835 |
| Operating Expenses | 6,693 | 8,556 | 15,425 | 34,306 | 15,812 |
| Operating Income | -3,648 | -6,102 | -14,007 | -35,526 | -12,778 |
| Interest Expense | 0 | 0 | 0 | 20 | 47 |
| Other Income | -661 | 781 | 3,193 | 19,414 | 6,675 |
| Pre-tax Income | -4,309 | -5,321 | -10,814 | -16,132 | -6,150 |
| Income Tax | 8 | 8 | 14 | 2 | -124 |
| Net Income Continuous | -4,317 | -5,329 | -10,828 | -16,134 | -6,026 |
| Net Income Discontinuous | -2,721 | -8,657 | -4,784 | N/A | N/A |
| Minority Interests | N/A | -5 | -236 | -1,474 | -1,371 |
| Net Income | $-7,038 | $-13,981 | $-15,376 | $-14,660 | $-4,655 |
| EPS Basic Total Ops | -5.17 | -11.29 | -25.65 | -27.56 | -18.80 |
| EPS Basic Continuous Ops | -3.17 | -4.30 | -17.67 | -30.33 | -24.20 |
| EPS Basic Discontinuous Ops | -2.00 | -6.99 | -7.98 | N/A | N/A |
| EPS Diluted Total Ops | -5.17 | -11.29 | -25.65 | -27.56 | -18.80 |
| EPS Diluted Continuous Ops | -3.17 | -4.30 | -17.67 | -30.33 | -24.20 |
| EPS Diluted Discontinuous Ops | -2.00 | -6.99 | -7.98 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -3.17 | -11.02 | -26.08 | -52.00 | -64.80 |
| EBITDA(a) | $-3,040 | $-5,118 | $-12,240 | $-28,255 | $-11,112 |